NCT01964963View on ClinicalTrials.gov

Alogliptin Tablets Special Drug Use Surveillance: Mild Type 2 Diabetes Mellitus

CompletedOBSERVATIONAL

Enrollment

19,192

Participants

Timeline

Start Date

August 3, 2011

Primary Completion Date

July 31, 2017

Study Completion Date

July 31, 2017

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG

Alogliptin

Alogliptin tablets

Trial Locations (1)

Unknown

Tokyo

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Takeda

INDUSTRY

NCT01964963 - Alogliptin Tablets Special Drug Use Surveillance: Mild Type 2 Diabetes Mellitus | Biotech Hunter | Biotech Hunter